Regeneron Pharmaceuticals
Regeneron is seeking an experienced scientist specializing in analytical characterization to support biologics and biotherapeutics development. The role involves developing and executing biochemical and biophysical workflows, understanding degradation profiles, and collaborating across teams.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
5% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Principal Scientist – Lead Discovery and Targeted Protein Degradation Biochemistry
Amgen
Scientist, Protein Sciences & Analytics, Biologics Engineering -High throughput Developability assays-
AstraZeneca
Scientist - Protein Biochemistry
GSK plc
Senior Research Associate, Protein Science Developability
Lila Sciences
VIE Scientist: Biochemistry and Biophysics
UCB
VIE Scientist: Biochemistry and Biophysics
UCB